Search research articles
Contact Us
Filters
Showing results (71-80 of 176) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Cancer Immunology, Immunotherapy : CII
|
December 6, 2017
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome
Larisa J Geskin, Oleg E Akilov, Soonyou Kwon, et al.
Oncoimmunology
|
June 28, 2012
Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity
Leeann T Blalock, Jennifer Landsberg, Michelle Messmer, et al.
The Journal of Experimental Medicine
|
May 6, 2020
Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses
Patricia M Santos, Juraj Adamik, Timothy R Howes, et al.
Cancer Immunology Research
|
October 14, 2020
Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma
Deena M Maurer, Juraj Adamik, Patricia M Santos, et al.
Cancer Immunology Research
|
June 1, 2023
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade
Xiaoyu Li, Jingjing Li, Yue Zheng, et al.
Journal of Translational Medicine
|
November 20, 2010
Zinc in innate and adaptive tumor immunity
Erica John, Thomas C Laskow, William J Buchser, et al.
Cancer Immunology, Immunotherapy : CII
|
November 24, 2011
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma
Theresa L Whiteside, Lisa H Butterfield, Paul H Naylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2004
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells
Yu-Pei Liao, Chun-Chieh Wang, Lisa H Butterfield, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 176) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Cancer Immunology, Immunotherapy : CII
|
December 6, 2017
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome
Larisa J Geskin, Oleg E Akilov, Soonyou Kwon, et al.
Oncoimmunology
|
June 28, 2012
Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity
Leeann T Blalock, Jennifer Landsberg, Michelle Messmer, et al.
The Journal of Experimental Medicine
|
May 6, 2020
Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses
Patricia M Santos, Juraj Adamik, Timothy R Howes, et al.
Cancer Immunology Research
|
October 14, 2020
Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma
Deena M Maurer, Juraj Adamik, Patricia M Santos, et al.
Cancer Immunology Research
|
June 1, 2023
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade
Xiaoyu Li, Jingjing Li, Yue Zheng, et al.
Journal of Translational Medicine
|
November 20, 2010
Zinc in innate and adaptive tumor immunity
Erica John, Thomas C Laskow, William J Buchser, et al.
Cancer Immunology, Immunotherapy : CII
|
November 24, 2011
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma
Theresa L Whiteside, Lisa H Butterfield, Paul H Naylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M Kirkwood, Sandra Lee, Stergios J Moschos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 6, 2004
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells
Yu-Pei Liao, Chun-Chieh Wang, Lisa H Butterfield, et al.
Page
of 18